1. Home
  2. Author
  3. Schneider L

Schneider L

References (19)

Title : Memantine for dementia - McShane_2019_Cochrane.Database.Syst.Rev_3_CD003154
Author(s) : McShane R , Westby MJ , Roberts E , Minakaran N , Schneider L , Farrimond LE , Maayan N , Ware J , Debarros J
Ref : Cochrane Database Syst Rev , 3 :CD003154 , 2019
Abstract :
PubMedSearch : McShane_2019_Cochrane.Database.Syst.Rev_3_CD003154
PubMedID: 30891742

Title : Treatment Options for Agitation in Dementia - Ringman_2019_Curr.Treat.Options.Neurol_21_30
Author(s) : Ringman JM , Schneider L
Ref : Curr Treat Options Neurol , 21 :30 , 2019
Abstract :
PubMedSearch : Ringman_2019_Curr.Treat.Options.Neurol_21_30
PubMedID: 31231784

Title : The Physcomitrella patens chromosome-scale assembly reveals moss genome structure and evolution - Lang_2018_Plant.J_93_515
Author(s) : Lang D , Ullrich KK , Murat F , Fuchs J , Jenkins J , Haas FB , Piednoel M , Gundlach H , Van Bel M , Meyberg R , Vives C , Morata J , Symeonidi A , Hiss M , Muchero W , Kamisugi Y , Saleh O , Blanc G , Decker EL , van Gessel N , Grimwood J , Hayes RD , Graham SW , Gunter LE , McDaniel SF , Hoernstein SNW , Larsson A , Li FW , Perroud PF , Phillips J , Ranjan P , Rokshar DS , Rothfels CJ , Schneider L , Shu S , Stevenson DW , Thummler F , Tillich M , Villarreal Aguilar JC , Widiez T , Wong GK , Wymore A , Zhang Y , Zimmer AD , Quatrano RS , Mayer KFX , Goodstein D , Casacuberta JM , Vandepoele K , Reski R , Cuming AC , Tuskan GA , Maumus F , Salse J , Schmutz J , Rensing SA
Ref : Plant J , 93 :515 , 2018
Abstract :
PubMedSearch : Lang_2018_Plant.J_93_515
PubMedID: 29237241
Gene_locus related to this paper: phypa-a9tc36 , phypa-a0a2k1kfe3 , phypa-a9sqk3 , phypa-a0a2k1ie71 , phypa-a0a2k1kg29 , phypa-a0a2k1iji3

Title : New therapeutic approaches and novel alternatives for organophosphate toxicity - Katz_2018_Toxicol.Lett_291_1
Author(s) : Katz FS , Pecic S , Schneider L , Zhu Z , Hastings A , Luzac M , MacDonald J , Landry DW , Stojanovic MN
Ref : Toxicol Lett , 291 :1 , 2018
Abstract :
PubMedSearch : Katz_2018_Toxicol.Lett_291_1
PubMedID: 29614332

Title : Cover Picture: Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates (ChemBioChem 15\/2015) - Katz_2015_Chembiochem_16_2113
Author(s) : Katz FS , Pecic S , Tran TH , Trakht I , Schneider L , Zhu Z , Ton-That L , Luzac M , Zlatanic V , Damera S , MacDonald J , Landry DW , Tong L , Stojanovic MN
Ref : Chembiochem , 16 :2113 , 2015
Abstract :
PubMedSearch : Katz_2015_Chembiochem_16_2113
PubMedID: 26444304

Title : Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates - Katz_2015_Chembiochem_16_2205
Author(s) : Katz FS , Pecic S , Tran TH , Trakht I , Schneider L , Zhu Z , Ton-That L , Luzac M , Zlatanic V , Damera S , MacDonald J , Landry DW , Tong L , Stojanovic MN
Ref : Chembiochem , 16 :2205 , 2015
Abstract :
PubMedSearch : Katz_2015_Chembiochem_16_2205
PubMedID: 26350723
Gene_locus related to this paper: mouse-ACHE

Title : Pharmacologic cholinesterase inhibition improves survival in experimental sepsis - Hofer_2008_Crit.Care.Med_36_404
Author(s) : Hofer S , Eisenbach C , Lukic IK , Schneider L , Bode K , Brueckmann M , Mautner S , Wente MN , Encke J , Werner J , Dalpke AH , Stremmel W , Nawroth PP , Martin E , Krammer PH , Bierhaus A , Weigand MA
Ref : Critical Care Medicine , 36 :404 , 2008
Abstract :
PubMedSearch : Hofer_2008_Crit.Care.Med_36_404
PubMedID: 18091537

Title : Galantamine for Alzheimer's disease and mild cognitive impairment - Loy_2006_Cochrane.Database.Syst.Rev__CD001747
Author(s) : Loy C , Schneider L
Ref : Cochrane Database Syst Rev , :CD001747 , 2006
Abstract :
PubMedSearch : Loy_2006_Cochrane.Database.Syst.Rev__CD001747
PubMedID: 16437436

Title : Metrifonate for Alzheimer's disease - Lopez-Arrieta_2006_Cochrane.Database.Syst.Rev__CD003155
Author(s) : Lopez-Arrieta JM , Schneider L
Ref : Cochrane Database Syst Rev , :CD003155 , 2006
Abstract :
PubMedSearch : Lopez-Arrieta_2006_Cochrane.Database.Syst.Rev__CD003155
PubMedID: 16625573

Title : Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease - Cummings_2004_Am.J.Psychiatry_161_532
Author(s) : Cummings JL , Schneider L , Tariot PN , Kershaw PR , Yuan W
Ref : Am J Psychiatry , 161 :532 , 2004
Abstract :
PubMedSearch : Cummings_2004_Am.J.Psychiatry_161_532
PubMedID: 14992980

Title : Galantamine for Alzheimer's disease - Loy_2004_Cochrane.Database.Syst.Rev__CD001747
Author(s) : Loy C , Schneider L
Ref : Cochrane Database Syst Rev , :CD001747 , 2004
Abstract :
PubMedSearch : Loy_2004_Cochrane.Database.Syst.Rev__CD001747
PubMedID: 15495017

Title : Galantamine for Alzheimer's disease (Cochrane Review) - Olin_2002_Cochrane.Database.Syst.Rev__CD001747
Author(s) : Olin J , Schneider L
Ref : Cochrane Database Syst Rev , :CD001747 , 2002
Abstract :
PubMedSearch : Olin_2002_Cochrane.Database.Syst.Rev__CD001747
PubMedID: 12137632

Title : Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? - Winblad_2001_Int.J.Geriatr.Psychiatry_16_653
Author(s) : Winblad B , Brodaty H , Gauthier S , Morris JC , Orgogozo JM , Rockwood K , Schneider L , Takeda M , Tariot P , Wilkinson D
Ref : Int J Geriatr Psychiatry , 16 :653 , 2001
Abstract :
PubMedSearch : Winblad_2001_Int.J.Geriatr.Psychiatry_16_653
PubMedID: 11466744

Title : Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors - Sands_1999_Alzheimer.Dis.Assoc.Disord_13_26
Author(s) : Sands LP , Katz I , Schneider L
Ref : Alzheimer Disease & Associated Disorders , 13 :26 , 1999
Abstract :
PubMedSearch : Sands_1999_Alzheimer.Dis.Assoc.Disord_13_26
PubMedID: 10192639

Title : Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease - Farlow_1998_Neurology_50_669
Author(s) : Farlow MR , Lahiri DK , Poirier J , Davignon J , Schneider L , Hui SL
Ref : Neurology , 50 :669 , 1998
Abstract :
PubMedSearch : Farlow_1998_Neurology_50_669
PubMedID: 9521254

Title : Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration - Qizilbash_1998_Jama_280_1777
Author(s) : Qizilbash N , Whitehead A , Higgins J , Wilcock G , Schneider L , Farlow M
Ref : Jama , 280 :1777 , 1998
Abstract :
PubMedSearch : Qizilbash_1998_Jama_280_1777
PubMedID: 9842955

Title : Long-term tacrine treatment effects -
Author(s) : Knopman D , Schneider L , Davis K , Gracon S , Smith F
Ref : Neurology , 50 :567 , 1998
PubMedID: 9484404

Title : Treating Alzheimer's disease.Pharmacologic options now and in the near future - Tariot_1997_Postgrad.Med_101_73
Author(s) : Tariot PN , Schneider L , Porsteinsson AP
Ref : Postgrad Med , 101 :73 , 1997
Abstract :
PubMedSearch : Tariot_1997_Postgrad.Med_101_73
PubMedID: 9194867

Title : Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group - Knopman_1996_Neurology_47_166
Author(s) : Knopman D , Schneider L , Davis K , Talwalker S , Smith F , Hoover T , Gracon S
Ref : Neurology , 47 :166 , 1996
Abstract :
PubMedSearch : Knopman_1996_Neurology_47_166
PubMedID: 8710072